clinical trial · NCT06657144
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Metastatic Solid TumorAdvanced Solid TumorCHS-114Toripalimab5 FluorouracilCisplatin
brief summary
The main purpose of this study is to evaluate the safety and preliminary efficacy of CHS-114 in combination with toripalimab and/or other standard of care (SOC) compound(s) in participants with advanced or metastatic solid tumors.
started
Apr 1, 2025
primary completion
Jan 1, 2028
completion
Jan 1, 2028
last updated
Apr 6, 2026
official title
A Phase 1B, Multicenter, Open-Label Study of the Safety and Efficacy of CHS-114 in Combination With Toripalimab With or Without Other Treatments in Participants With Advanced or Metastatic Solid Tumors (TREGCHECK 102)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol